newsfilter
← Latest News
GlobeNewswire·

Athenex Announces MHRA Decision on Oral Paclitaxel

MHRA denies Oral Paclitaxel for metastatic breast cancer based solely on chemistry, manufacturing and control (CMC) issuesAthenex plans to request a review of the MHRA decision by an independent panel The MHRA